サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1562404

アジア太平洋の非経口栄養：2030年までの市場予測 - 地域分析 - 栄養剤タイプ別、エンドユーザー別

Asia Pacific Parenteral Nutrition Market Forecast to 2030 - Regional Analysis - by Nutrient Type and End User

出版日
ページ情報
英文 95 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
アジア太平洋の非経口栄養：2030年までの市場予測 - 地域分析 - 栄養剤タイプ別、エンドユーザー別
出版日: 2024年07月04日
発行: The Insight Partners
ページ情報: 英文 95 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アジア太平洋の非経口栄養市場は、2022年に8億6,159万米ドルと評価され、2030年には14億7,133万米ドルに達すると予測され、2022年から2030年までのCAGRは6.9%を記録すると予測されています。

企業による新製品開発がアジア太平洋の非経口栄養市場を押し上げる

非経口医療用栄養市場で事業を展開する企業は、常に新製品の発売に注力し、売上向上に貢献しています。

2023年、韓国バクスターは、重症患者用のタンパク質豊富な総合非経口栄養（TPN）輸液であるオリメルN12Eを発売しました。

2023年には、JWホールディングスが、現地の製薬会社AsiaPharma LLCを通じて、モンゴル向けに3室型経腸栄養剤ウィヌフセントラル736/1,085mlの大規模輸出を開始しました。

このように、栄養の新製品開拓は、予測期間中に市場成長の機会を創出すると予想されます。

アジア太平洋の非経口栄養市場の概要

中国では、国民の間でピロリ菌感染の有病率が高まっているため、胃がんの負担が大きいです。世界保健機関（WHO）の国際がん研究機関（IARC）と英国と中国の提携機関による調査（2021年）で、中国ではピロリ菌感染が流行していることが判明しました。さらに、ピロリ菌感染は、30歳以上の成人における心窩部胃がん症例の62.1％、非心窩部胃がん症例の78.5％の主要原因でした。IARCによるこの研究では、ピロリ菌感染による胃がん症例が中国では毎年34万件発生していると推定されています。2020年10月に発表されたGlobal Burden of Diseases研究によると、胃がんは2019年の死因トップ10に入っています。同様に、国際がん研究機関（IARC）の最新データによると、中国における胃がんの推定年齢標準化罹患率は10万人当たり20.58人、粗罹患率は33.06人です。同じ出典によると、2020年の新規患者数（0～74歳）は男女とも478,508人と推定されています。したがって、上記の要因から、非経口栄養市場は予測期間中に中国で著しい成長を遂げる可能性が高いです。

アジア太平洋の非経口栄養市場の収益と2030年までの予測（金額）

アジア太平洋の非経口栄養市場のセグメンテーション

アジア太平洋の非経口栄養市場は、栄養素タイプ、エンドユーザー、国によって区分されます。栄養素タイプに基づき、アジア太平洋の非経口栄養市場は、単回投与アミノ酸溶液、非経口脂質エマルジョン、炭水化物、微量元素、ビタミン・ミネラルに分類されます。単回投与アミノ酸溶液セグメントが2022年に最大の市場シェアを占めました。

エンドユーザー別では、アジア太平洋の非経口栄養市場は病院、診療所、その他に区分されます。病院セグメントが2022年に最大の市場シェアを占めました。

国別では、アジア太平洋の非経口栄養市場は中国、日本、インド、オーストラリア、韓国、その他アジア太平洋に区分されます。2022年のアジア太平洋の非経口栄養市場シェアは中国が独占しました。

ICU Medical Inc、Grifols SA、Pfizer Inc、大塚製薬株式会社、Baxter International Inc、B Braun SE、Fresenius Kabi AG、Aculife Healthcare Pvt Ltd、Sichuan Kelun-Biotech Biopharmaceutical Co Ltd、Vifor Pharma Management AGは、アジア太平洋の非経口栄養市場で事業を展開する大手企業の一部です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 アジア太平洋の非経口栄養市場-主要産業力学

  • 市場促進要因
    • 胃腸疾患の有病率の上昇
    • 栄養不良と早産のケースの急増
  • 市場抑制要因
    • 非経口栄養システムに関連する機械的、消化管的、代謝的合併症
  • 市場機会
    • 企業による新製品開発
  • 今後の動向
    • 栄養製品の処方革新
  • 影響分析

第5章 非経口栄養市場：アジア太平洋市場分析

  • 非経口栄養市場の収益、2020年～2030年

第6章 アジア太平洋の非経口栄養市場分析：栄養素タイプ別

  • 単回投与アミノ酸溶液
  • 非経口脂質エマルジョン
  • 炭水化物
  • 微量元素
  • ビタミンとミネラル

第7章 アジア太平洋の非経口栄養市場分析：エンドユーザー別

  • 病院
  • 診療所
  • その他

第8章 アジア太平洋の非経口栄養市場：国別分析

  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
    • その他アジア太平洋

第9章 業界情勢

第10章 企業プロファイル

  • ICU Medical Inc
  • Grifols SA
  • Pfizer Inc
  • Otsuka Pharmaceuticals Co Ltd
  • Baxter International Inc
  • B Braun SE
  • Fresenius Kabi AG
  • Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
  • Vifor Pharma Management AG
  • Aculife Healthcare Pvt Ltd

第11章 付録

図表

List Of Tables

  • Table 1. Parenteral Nutrition Market Segmentation
  • Table 2. China: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
  • Table 3. China: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 4. Japan: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
  • Table 5. Japan: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 6. India: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
  • Table 7. India: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 8. Australia: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
  • Table 9. Australia: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 10. South Korea: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
  • Table 11. South Korea: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 12. Rest of Asia Pacific: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
  • Table 13. Rest of Asia Pacific: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 14. Recent Organic Growth Strategies in the Parenteral Nutrition Market
  • Table 15. Glossary of Terms, Parenteral Nutrition Market

List Of Figures

  • Figure 1. Parenteral Nutrition Market Segmentation, By Country
  • Figure 2. Parenteral Nutrition Market: Key Industry Dynamics
  • Figure 3. Parenteral Nutrition Market: Impact Analysis of Drivers and Restraints
  • Figure 4. Parenteral Nutrition Market Revenue (US$ Mn), 2020 - 2030
  • Figure 5. Parenteral Nutrition Market Share (%) - by Nutrient Type (2022 and 2030)
  • Figure 6. Single Dose Amino Acid Solution: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Parenteral Lipid Emulsion: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Carbohydrates: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Trace Elements: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Vitamins and Minerals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Parenteral Nutrition Market Share (%) - by End User (2022 and 2030)
  • Figure 12. Hospitals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Clinics: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Others: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Asia Pacific: Parenteral Nutrition Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 16. Asia Pacific: Parenteral Nutrition Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 17. China: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 18. Japan: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 19. India: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 20. Australia: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 21. South Korea: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 22. Rest of Asia Pacific: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
目次
Product Code: BMIRE00030378

The Asia Pacific parenteral nutrition market was valued at US$ 861.59 million in 2022 and is expected to reach US$ 1,471.33 million by 2030; it is estimated to record a CAGR of 6.9% from 2022 to 2030.

New Product Developments by Companies Boost Asia Pacific Parenteral Nutrition Market

Companies operating in the parenteral medical nutrition market constantly focus on new product launches, which help them improve their sales. A few of the noteworthy developments in the parenteral nutrition market are mentioned below:

In 2023, Baxter Korea launched Olimel N12E, a protein-rich Total Parenteral Nutrition (TPN) fluid for critically ill patients.

In 2023, JW Holdings started exporting Winuf Central 736/1,085ml, a three-chamber total parenteral nutrition (TPN), on a large scale to Mongolia via AsiaPharma LLC, a local pharmaceutical company.

Thus, new product development of nutrition is anticipated to create opportunities for the market growth during the forecast period.

Asia Pacific Parenteral Nutrition Market Overview

China faces a high burden of stomach cancer due to the growing prevalence of H. pylori infection among the people. A study (2021) by the World Health Organization's International Agency for Research on Cancer (IARC) and partner institutions in the UK and China found that H. pylori infection is prevalent in China. Furthermore, H. pylori infection was the prime cause for 62.1% of cardia gastric cancer cases and 78.5% of non-cardia gastric cancer cases among adults over 30 years of age. This study by IARC estimated that ~340,000 cases of gastric cancer due to H. pylori infection occur in China every year. According to Global Burden of Diseases study published in October 2020, stomach cancer was among the top 10 causes of death in 2019. Similarly, according to the latest data from the International Agency for Research on Cancer (IARC), the estimated age-standardized incidence rate for stomach cancer in China is 20.58 per 100,000, and the crude rate is 33.06. As per the same source, the estimated number of new cases (aged 0-74) in 2020 for both sexes was 478,508. Thus, owing to the abovementioned factors, the market for parenteral nutrition is likely to witness remarkable growth in China during the forecast period.

Asia Pacific Parenteral Nutrition Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Parenteral Nutrition Market Segmentation

The Asia Pacific parenteral nutrition market is segmented based on nutrient type, end user, and country. Based on nutrient type, the Asia Pacific parenteral nutrition market is categorized into single dose amino acid solution, parenteral lipid emulsion, carbohydrates, trace elements, and vitamins and minerals. The single dose amino acid solution segment held the largest market share in 2022.

By end user, the Asia Pacific parenteral nutrition market is segmented into hospitals, clinics, and others. The hospitals segment held the largest market share in 2022.

Based on country, the Asia Pacific parenteral nutrition market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific parenteral nutrition market share in 2022.

ICU Medical Inc, Grifols SA, Pfizer Inc, Otsuka Pharmaceuticals Co Ltd, Baxter International Inc, B Braun SE, Fresenius Kabi AG, Aculife Healthcare Pvt Ltd, Sichuan Kelun-Biotech Biopharmaceutical Co Ltd, and Vifor Pharma Management AG are some of the leading players operating in the Asia Pacific parenteral nutrition market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Parenteral Nutrition Market - Key Industry Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Rise in Prevalence of Gastrointestinal Diseases
    • 4.1.2 Surge in Cases of Malnutrition and Premature Births
  • 4.2 Market Restraints
    • 4.2.1 Mechanical, Gastrointestinal, and Metabolic Complications Associated with Parenteral Feeding Systems
  • 4.3 Market Opportunities
    • 4.3.1 New Product Developments by Companies
  • 4.4 Future Trends
    • 4.4.1 Innovation in Formulations of Nutrition Products
  • 4.5 Impact Analysis

5. Parenteral Nutrition Market - Asia Pacific Market Analysis

  • 5.1 Overview
  • 5.2 Parenteral Nutrition Market Revenue (US$ Mn), 2020 - 2030

6. Asia Pacific Parenteral Nutrition Market Analysis - by Nutrient Type

  • 6.1 Overview
  • 6.2 Single Dose Amino Acid Solution
    • 6.2.1 Overview
    • 6.2.2 Single Dose Amino Acid Solution: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.3 Parenteral Lipid Emulsion
    • 6.3.1 Overview
    • 6.3.2 Parenteral Lipid Emulsion: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Carbohydrates
    • 6.4.1 Overview
    • 6.4.2 Carbohydrates: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.5 Trace Elements
    • 6.5.1 Overview
    • 6.5.2 Trace Elements: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.6 Vitamins and Minerals
    • 6.6.1 Overview
    • 6.6.2 Vitamins and Minerals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific Parenteral Nutrition Market Analysis - by End User

  • 7.1 Overview
  • 7.2 Hospitals
    • 7.2.1 Overview
    • 7.2.2 Hospitals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Clinics
    • 7.3.1 Overview
    • 7.3.2 Clinics: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Others
    • 7.4.1 Overview
    • 7.4.2 Others: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Parenteral Nutrition Market - Country Analysis

  • 8.1 Asia Pacific
    • 8.1.1 Asia Pacific: Parenteral Nutrition Market - Revenue and Forecast Analysis - by Country
      • 8.1.1.1 China: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
        • 8.1.1.1.1 Overview
        • 8.1.1.1.2 China: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
        • 8.1.1.1.3 China: Parenteral Nutrition Market Breakdown, by Nutrient Type
        • 8.1.1.1.4 China: Parenteral Nutrition Market Breakdown, by End User
      • 8.1.1.2 Japan: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
        • 8.1.1.2.1 Overview
        • 8.1.1.2.2 Japan: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
        • 8.1.1.2.3 Japan: Parenteral Nutrition Market Breakdown, by Nutrient Type
        • 8.1.1.2.4 Japan: Parenteral Nutrition Market Breakdown, by End User
      • 8.1.1.3 India: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
        • 8.1.1.3.1 Overview
        • 8.1.1.3.2 India: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
        • 8.1.1.3.3 India: Parenteral Nutrition Market Breakdown, by Nutrient Type
        • 8.1.1.3.4 India: Parenteral Nutrition Market Breakdown, by End User
      • 8.1.1.4 Australia: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
        • 8.1.1.4.1 Overview
        • 8.1.1.4.2 Australia: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
        • 8.1.1.4.3 Australia: Parenteral Nutrition Market Breakdown, by Nutrient Type
        • 8.1.1.4.4 Australia: Parenteral Nutrition Market Breakdown, by End User
      • 8.1.1.5 South Korea: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
        • 8.1.1.5.1 Overview
        • 8.1.1.5.2 South Korea: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
        • 8.1.1.5.3 South Korea: Parenteral Nutrition Market Breakdown, by Nutrient Type
        • 8.1.1.5.4 South Korea: Parenteral Nutrition Market Breakdown, by End User
      • 8.1.1.6 Rest of Asia Pacific: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
        • 8.1.1.6.1 Overview
        • 8.1.1.6.2 Rest of Asia Pacific: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
        • 8.1.1.6.3 Rest of Asia Pacific: Parenteral Nutrition Market Breakdown, by Nutrient Type
        • 8.1.1.6.4 Rest of Asia Pacific: Parenteral Nutrition Market Breakdown, by End User

9. Industry Landscape

  • 9.1 Overview
    • 9.1.1 Overview

10. Company Profiles

  • 10.1 ICU Medical Inc
    • 10.1.1 Key Facts
    • 10.1.2 Business Description
    • 10.1.3 Products and Services
    • 10.1.4 Financial Overview
    • 10.1.5 SWOT Analysis
    • 10.1.6 Key Developments
  • 10.2 Grifols SA
    • 10.2.1 Key Facts
    • 10.2.2 Business Description
    • 10.2.3 Products and Services
    • 10.2.4 Financial Overview
    • 10.2.5 SWOT Analysis
    • 10.2.6 Key Developments
  • 10.3 Pfizer Inc
    • 10.3.1 Key Facts
    • 10.3.2 Business Description
    • 10.3.3 Products and Services
    • 10.3.4 Financial Overview
    • 10.3.5 SWOT Analysis
    • 10.3.6 Key Developments
  • 10.4 Otsuka Pharmaceuticals Co Ltd
    • 10.4.1 Key Facts
    • 10.4.2 Business Description
    • 10.4.3 Products and Services
    • 10.4.4 Financial Overview
    • 10.4.5 SWOT Analysis
    • 10.4.6 Key Developments
  • 10.5 Baxter International Inc
    • 10.5.1 Key Facts
    • 10.5.2 Business Description
    • 10.5.3 Products and Services
    • 10.5.4 Financial Overview
    • 10.5.5 SWOT Analysis
    • 10.5.6 Key Developments
  • 10.6 B Braun SE
    • 10.6.1 Key Facts
    • 10.6.2 Business Description
    • 10.6.3 Products and Services
    • 10.6.4 Financial Overview
    • 10.6.5 SWOT Analysis
    • 10.6.6 Key Developments
  • 10.7 Fresenius Kabi AG
    • 10.7.1 Key Facts
    • 10.7.2 Business Description
    • 10.7.3 Products and Services
    • 10.7.4 Financial Overview
    • 10.7.5 SWOT Analysis
    • 10.7.6 Key Developments
  • 10.8 Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
    • 10.8.1 Key Facts
    • 10.8.2 Business Description
    • 10.8.3 Products and Services
    • 10.8.4 Financial Overview
    • 10.8.5 SWOT Analysis
    • 10.8.6 Key Developments
  • 10.9 Vifor Pharma Management AG
    • 10.9.1 Key Facts
    • 10.9.2 Business Description
    • 10.9.3 Products and Services
    • 10.9.4 Financial Overview
    • 10.9.5 SWOT Analysis
    • 10.9.6 Key Developments
  • 10.10 Aculife Healthcare Pvt Ltd
    • 10.10.1 Key Facts
    • 10.10.2 Business Description
    • 10.10.3 Products and Services
    • 10.10.4 Financial Overview
    • 10.10.5 SWOT Analysis
    • 10.10.6 Key Developments

11. Appendix

  • 11.1 About The Insight Partners
  • 11.2 Glossary of Terms